APTO On The Move, PLX To Effect Reverse Split, SCYX Plunges

Today’s Daily Dose brings you news about Aurinia Pharma’s secondary offering; Aptose Biosciences’ early clinical data of CG-806 and APTO-253; the proposed reverse stock split of Protalix BioTherapeutics and Gilead’s path forward for KTE-X19 in the treatment for relapsed or refractory mantle cell lymphoma. Read on… Aurinia Pharmaceuticals Inc. (AUPH) […]

» Read more
1 2 3 187